Table of Contents

2019-2024 Global Neuroprotective Agents Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Neuroprotective Agents Market Size 2014-2024
  • 2.1.2 Neuroprotective Agents Market Size CAGR by Region
• 2.2 Neuroprotective Agents Segment by Type
  • 2.2.1 Cerebrovascular Diseases
  • 2.2.2 Neurodegenerative Disorders
  • 2.2.3 Ophthalmic Diseases
  • 2.2.4 Traumatic CNS Injuries
• 2.3 Neuroprotective Agents Market Size by Type
  • 2.3.1 Global Neuroprotective Agents Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Neuroprotective Agents Market Size Growth Rate by Type (2014-2019)
• 2.4 Neuroprotective Agents Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Others
• 2.5 Neuroprotective Agents Market Size by Application
  • 2.5.1 Global Neuroprotective Agents Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Neuroprotective Agents Market Size Growth Rate by Application (2014-2019)

3 Global Neuroprotective Agents by Players

• 3.1 Global Neuroprotective Agents Market Size Market Share by Players
  • 3.1.1 Global Neuroprotective Agents Market Size by Players (2017-2019)
  • 3.1.2 Global Neuroprotective Agents Market Size Market Share by Players (2017-2019)
• 3.2 Global Neuroprotective Agents Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Neuroprotective Agents by Regions

• 4.1 Neuroprotective Agents Market Size by Regions
• 4.2 Americas Neuroprotective Agents Market Size Growth
• 4.3 APAC Neuroprotective Agents Market Size Growth
• 4.4 Europe Neuroprotective Agents Market Size Growth
• 4.5 Middle East & Africa Neuroprotective Agents Market Size Growth

5 Americas

• 5.1 Americas Neuroprotective Agents Market Size by Countries
• 5.2 Americas Neuroprotective Agents Market Size by Type
• 5.3 Americas Neuroprotective Agents Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Neuroprotective Agents Market Size by Countries
• 6.2 APAC Neuroprotective Agents Market Size by Type
• 6.3 APAC Neuroprotective Agents Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Neuroprotective Agents by Countries
• 7.2 Europe Neuroprotective Agents Market Size by Type
• 7.3 Europe Neuroprotective Agents Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Neuroprotective Agents by Countries
• 8.2 Middle East & Africa Neuroprotective Agents Market Size by Type
• 8.3 Middle East & Africa Neuroprotective Agents Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Neuroprotective Agents Market Forecast

• 10.1 Global Neuroprotective Agents Market Size Forecast (2019-2024)
• 10.2 Global Neuroprotective Agents Forecast by Regions
  • 10.2.1 Global Neuroprotective Agents Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Neuroprotective Agents Forecast by Type
• 10.8 Global Neuroprotective Agents Forecast by Application

11 Key Players Analysis

• 11.1 Genervon Biopharmaceuticals
  • 11.1.1 Company Details
  • 11.1.2 Neuroprotective Agents Product Offered
  • 11.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Genervon Biopharmaceuticals News
• 11.2 NeuroVive Pharmaceutical
  • 11.2.1 Company Details
  • 11.2.2 Neuroprotective Agents Product Offered
  • 11.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 NeuroVive Pharmaceutical News
• 11.3 Ceregene
  • 11.3.1 Company Details
  • 11.3.2 Neuroprotective Agents Product Offered
  • 11.3.3 Ceregene Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Ceregene News
• 11.4 Neuren Pharmaceuticals
  • 11.4.1 Company Details
  • 11.4.2 Neuroprotective Agents Product Offered
  • 11.4.3 Neuren Pharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Neuren Pharmaceuticals News
• 11.5 Allon Therapeutics
  • 11.5.1 Company Details
  • 11.5.2 Neuroprotective Agents Product Offered
  • 11.5.3 Allon Therapeutics Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Allon Therapeutics News

...

12 Research Findings and Conclusion

Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.

According to this study, over the next five years the Neuroprotective Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Neuroprotective Agents business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Neuroprotective Agents market by product type, application, key companies and key regions.

This study considers the Neuroprotective Agents value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cerebrovascular Diseases
Neurodegenerative Disorders
Traumatic CNS Injuries
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical
Ceregene
Neuren Pharmaceuticals
Allon Therapeutics
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Neuroprotective Agents market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neuroprotective Agents market by identifying its various subsegments.
Focuses on the key global Neuroprotective Agents players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neuroprotective Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Neuroprotective Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.